Chemical Compound
BETAMETHASONE VALERATE
CAS Registry Number
2152-44-5
Primary Record
BETAMETHASONE VALERATE
- In stock
- 6,586 g
- Purity
- 99.6 %
- CAS
- 2152-44-5
Compound Identifiers & Properties
- CAS
- 2152-44-5
- PubChem CID
- 16533
- SMILES
- CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CO
- Canonical SMILES
- CCCCC(=O)O[C@]1(C(=O)CO)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
Names & Synonyms
- BETAMETHASONE VALERATE
- Betamethasone 17-valerate
- Valisone
- Betnovate
- Betaderm
- Luxiq
- Tokuderm
- beta-Val
- Betatrex
- Dermabet
- Valnac
- Celestoderm
- Bedermin
- Bextasol
- Stanoval
- Rinderon V
- Betnovateat
- Betneval
- Dermosol
- 2152-44-5
- Bettamousse
- Dermovaleas
- Celestone
- Hormezon
- entanoate
- Betnesol-V
- Flubenisolonvalerate
- Audavate
- Bectmiran
- Betnevate
- Celeston valerate
- Fuciderm
- Keligroll
- Rinderon
- Xemacort
- Betaval
- Betesil
- Fucibet
- Betoid
- Nolcot
- Voalla ointment
- Betnovate rd
- Audavate rd
- Celestoderm V
- Celestoderm-V
- Tubeimoside I
- Mixture Name
- Celestane V
- Betnesol V
- Celestan V
- Celestan-V
- Ijilone V
- Betamethasoni valeras
- Ecoval 70
- Otomax (Veterinary)
- Topagen (Veterinary)
- Gentocin (Veterinary)
- Rinderon-V (TN)
- Valerate, Betamethasone
- betamethasone-valerate
- Luxiq (TN)
- Topagen (Salt/Mix)
- Beta-Val (TN)
- Betamethasone 17a-valerate
- Betatrex (Salt/Mix)
- Gentocin (Salt/Mix)
- beta-Methasone 17-valerate
- Betamethasone (as valerate)
- 9IFA5XM7R2
- Betamethasone-17-valerate
- Chlorophytum Borivilanum
- Betamethasone 17 Valerate
- RefChem:54532
- Betamethason-17-valerat
- DTXSID7022673
- 17-Valerate, Betamethasone
- C27H37FO6
- Betameth val in coal tar
- Betamethason-17-valerate
- Betamethasone valerate RS
- Valeric acid betamethasone
- SNHRLVCMMWUAJD-SUYDQAKGSA-N
- Betamethasone Valerate Foam
- D03SXE
- UNII-9IFA5XM7R2
- SCHEMBL7270
- DTXCID702673
- Betamethasone valerate (Betnovate)
- CHEMBL1497
- MFCD00867446
- CHEBI:31277
- Betamethasone 17alpha-valerate
- Betamethasone 17-valerate CRS
- AC1L285F
- orb1309553
- orb3025856
- NSC-755912
- EINECS 218-439-3
- ERK5-3N07
- HY-B0727R
- Betamethasone valerate (Standard)
- MSK2235
- Betnovate;Celestone;Betaderm;Luxiq
- GLXC-23436
- CID16533
- HY-B0727
- ZINC3882052
- Betamethasone valerate (JP18/USP)
- BETAMETHASONE VALERATE [JAN]
- Tox21_302288
- BETAMETHASONE VALERATE [USAN]
- CID:16533
- s1690
- BETAMETHASONE VALERATE [VANDF]
- AKOS015994704
- BETAMETHASONE VALERATE [MART.]
- ACN-036939
- BETAMETHASONE VALERATE [USP-RS]
- BETAMETHASONE VALERATE [WHO-DD]
- BETAMETHASONE VALERATE [WHO-IP]
- CCG-269509
- FB18564
- J7.337G
- KS-1198
- NSC 755912
- RL02645
- BETAMETHASONE 17-VALERATE [MI]
- Betamethasone valerate [USAN:BAN:JAN]
- Betamethasone valerate [USAN:USP:JAN]
- NCGC00255185-01
- NCGC00274064-01
- AN-14218
- SID:99222752
- ST075178
- SY074182
- BETAMETHASONE VALERATE [GREEN BOOK]
- CAS-2152-44-5
- AB2000222
- BETAMETHASONE VALERATE [ORANGE BOOK]
- LS-118456
- A8379
- BETAMETHASONE VALERATE [EP MONOGRAPH]
- Betamethasone valerate for system suitability
- BETAMETHASONI VALERAS [WHO-IP LATIN]
- CS-0009628
- NS00006017
- Betamethasone 17-valerate CRS (B1054000)
- BETAMETHASONE VALERATE [USP MONOGRAPH]
- 9?-Fluoro-16?-methylprednisolone 17-valerate
- A12274
- Betamethasone valerate, 99% - 250MG 250mg
- D01357
- AB01274710-01
- AB01274710_02
- Betamethasone valerate for system suitability CRS
- 152M445
- A815447
- D001624
- 9alpha-Fluoro-16beta-methylprednisolone 17-valerate
- Betamethasone Valerate (Betamethasone 17-Valerate)
- Q6445931
- 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate
- 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
- BRD-K34032314-001-02-5
- BRD-K34032314-001-04-1
- [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)-
- Betamethasone Valerate for system suitability CRS (Y0001027)
- 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate
- 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate
- 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate
- (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate
- Betamethasone Valerate Working Standard (Secondary Reference Standard)
- 9-Fluoro-11?,17,21-trihydroxy-16?-meth ylpregna-1,4-diene-3,20-dione 17-valerate
- 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-pentanoate
- (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate
- (11?,16?)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione
- (11beta,16beta)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione
- (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate
- (11S,16S)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17-valerate
- (1R,2S,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-10-hydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl pentanoate
- (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p
- (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate
- 1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate
- 102040-03-9
- 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate
- 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate #
- 9-Fluoro-11beta,21-dihydroxy-16beta-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione
- 9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate
- Betamethasone 17-Valerate; Betamethasone Valerate; Bedermin; Beta-Val; Betamethasone 17-valerate; Betamethasone valerate; Betnesol V; Betneval; Betnovate; Betnovateat; Betoid; Bettamousse; Bextasol; Celestan V; Celestane V; Celestoderm; Celestoderm V; Celeston valerate; Dermosol; Dermovaleas; Ecoval 70; Fuciderm; Hormezon; Rinderon V; Stanoval; Tokuderm; Valisone; (11beta,16beta)-9-Fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]pregna-1,4-diene-3,20-dione; 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate; Valeric acid 17-ester with 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione; 9alpha-Fluoro-11beta,21-dihydroxy-16beta-methyl-17alpha-valeryloxypregna-1,4-diene-3,20-dione; 9alpha-Fluoro-16beta-methylprednisolone 17-valerate; Betamethasone 17alpha-valerate; beta-Methasone 17-valerate; CS valerate; Betamethasone-21-valer
- PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,21-DIHYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)-, (11.BETA.,16.BETA.)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-[(1-oxopentyl)oxy]-, (11.beta.,16.beta.)-
- Valeric acid (11S,16S)-9-fluoro-11,21-dihydroxy-3,20-dioxo-16-methylpregna-1,4-diene-17-yl ester